A new tumor protein marker test has been developed by researchers working at the University of Wisconsin, which helps predict whether breast cancer will metastasize and spread to the brain. Spread of cancer to the brain is a deadly complication that may greatly reduce the survival chances of an individual to mere months after diagnosis. This new marker test would provide a diagnosis at an earlier stage and hence may help increase the survival rate of cancer patients.
Researchers working in the University of Wisconsin found that in mice alpha B-crystallin cell stress protein marker promoted brain metastasis in aggressive breast cancers that lacked expression of three different receptors: the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). Based on these above findings they further examined whether levels of alpha B-crystallin in…
